These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33218846)

  • 21. Prenatal Carrier Screening for Spinal Muscular Atrophy.
    Wood SL; Brewer F; Ellison R; Biggio JR; Edwards RK
    Am J Perinatol; 2016 Oct; 33(12):1211-7. PubMed ID: 27611803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newborn genetic screening for spinal muscular atrophy in the UK: The views of the general population.
    Boardman FK; Sadler C; Young PJ
    Mol Genet Genomic Med; 2018 Jan; 6(1):99-108. PubMed ID: 29169204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survey of patients with spinal muscular atrophy on the island of Shikoku, Japan.
    Okamoto K; Motoki T; Saito I; Urate R; Aibara K; Jogamoto T; Fukuda M; Wakamoto H; Maniwa S; Kondo Y; Toda Y; Goji A; Mori T; Soga T; Konishi Y; Nagai S; Takami Y; Tokorodani C; Nishiuchi R; Usui D; Ando R; Tada S; Yamanishi Y; Nagai M; Arakawa R; Saito K; Nishio H; Ishii E; Eguchi M
    Brain Dev; 2020 Sep; 42(8):594-602. PubMed ID: 32505480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carrier frequency of spinal muscular atrophy in Thailand.
    Dejsuphong D; Taweewongsounton A; Khemthong P; Chitphuk S; Stitchantrakul W; Sritara P; Tunteeratum A; Sura T
    Neurol Sci; 2019 Aug; 40(8):1729-1732. PubMed ID: 31004230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carrier screening for spinal muscular atrophy in 22913 Chinese reproductive age women.
    Zhang L; Mo J; Zhou L; Xu X; Xu Z; Zhang L; Wu W
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2359. PubMed ID: 38284446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mixed methods exploration of families' experiences of the diagnosis of childhood spinal muscular atrophy.
    Lawton S; Hickerton C; Archibald AD; McClaren BJ; Metcalfe SA
    Eur J Hum Genet; 2015 May; 23(5):575-80. PubMed ID: 25074464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.
    Feldkötter M; Schwarzer V; Wirth R; Wienker TF; Wirth B
    Am J Hum Genet; 2002 Feb; 70(2):358-68. PubMed ID: 11791208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. False Negative Carrier Screening in Spinal Muscular Atrophy.
    Butcher S; Smith M; Woodcock IR; Delatycki M; Ryan MM; Forbes R
    J Child Neurol; 2020 Mar; 35(4):274-277. PubMed ID: 31858866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SMN1 dosage analysis in spinal muscular atrophy from India.
    Kesari A; Rennert H; Leonard DG; Mittal B
    BMC Med Genet; 2005 May; 6():22. PubMed ID: 15910686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Infantile spinal atrophy: our experience in the last 25 years].
    Madrid Rodríguez A; Martínez Martínez PL; Ramos Fernández JM; Urda Cardona A; Martínez Antón J
    An Pediatr (Barc); 2015 Mar; 82(3):159-65. PubMed ID: 25103837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Cure SMA Membership Surveys: Highlights of Key Demographic and Clinical Characteristics of Individuals with Spinal Muscular Atrophy.
    Belter L; Jarecki J; Reyna SP; Cruz R; Jones CC; Schroth M; O'Toole CM; O'Brien S; Hall SA; Johnson NB; Paradis AD
    J Neuromuscul Dis; 2021; 8(1):109-123. PubMed ID: 33104036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spinal muscular atrophy carriers with two SMN1 copies.
    Ar Rochmah M; Awano H; Awaya T; Harahap NIF; Morisada N; Bouike Y; Saito T; Kubo Y; Saito K; Lai PS; Morioka I; Iijima K; Nishio H; Shinohara M
    Brain Dev; 2017 Nov; 39(10):851-860. PubMed ID: 28676237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation analysis of 419 family and prenatal diagnosis of 339 cases of spinal muscular atrophy in China.
    Sun Y; Kong X; Zhao Z; Zhao X
    BMC Med Genet; 2020 Jun; 21(1):133. PubMed ID: 32552676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolving approaches to prenatal genetic counseling for Spinal Muscular Atrophy in the new treatment era.
    Zettler B; Estrella E; Liaquat K; Lichten L
    J Genet Couns; 2022 Jun; 31(3):803-814. PubMed ID: 35037741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevalence of selected congenital anomalies in the Czech Republic: renal and cardiac anomalies and congenital chromosomal aberrations].
    Šípek A; Gregor V; Horáček J; Šípek A; Langhammer P
    Epidemiol Mikrobiol Imunol; 2013 Sep; 62(3):112-28. PubMed ID: 24116699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The implementation of newborn screening for spinal muscular atrophy: the Australian experience.
    Kariyawasam DST; Russell JS; Wiley V; Alexander IE; Farrar MA
    Genet Med; 2020 Mar; 22(3):557-565. PubMed ID: 31607747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years.
    Vill K; Schwartz O; Blaschek A; Gläser D; Nennstiel U; Wirth B; Burggraf S; Röschinger W; Becker M; Czibere L; Durner J; Eggermann K; Olgemöller B; Harms E; Schara U; Kölbel H; Müller-Felber W
    Orphanet J Rare Dis; 2021 Mar; 16(1):153. PubMed ID: 33789695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving detection and genetic counseling in carriers of spinal muscular atrophy with two copies of the SMN1 gene.
    Alías L; Barceló MJ; Bernal S; Martínez-Hernández R; Also-Rallo E; Vázquez C; Santana A; Millán JM; Baiget M; Tizzano EF
    Clin Genet; 2014 May; 85(5):470-5. PubMed ID: 23799925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spinal muscular atrophy carrier frequency and estimated prevalence of the disease in Moroccan newborns.
    Lyahyai J; Sbiti A; Barkat A; Ratbi I; Sefiani A
    Genet Test Mol Biomarkers; 2012 Mar; 16(3):215-8. PubMed ID: 21950724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular analysis and prenatal prediction of spinal muscular atrophy in Chinese patients by the combination of restriction fragment length polymorphism analysis, denaturing high-performance liquid chromatography, and linkage analysis.
    Chen WJ; Wu ZY; Lin MT; Su JF; Lin Y; Murong SX; Wang N
    Arch Neurol; 2007 Feb; 64(2):225-31. PubMed ID: 17296838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.